Personalized Medicine in Chronic Rhinosinusitis: Treatable Traits Using Biologics for Unmet Needs
Open Access
- 1 January 2025
- journal article
- research article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (1) , 8-21
Abstract
Okano M, et al. Allergy Asthma Immunol Res. 2025 Jan;17(1):8-21. https://doi.org/10.4168/aair.2025.17.1.8Keywords
This publication has 67 references indexed in Scilit:
- Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectivesAuris Nasus Larynx, 2023
- Update on allergic fungal rhinosinusitisAnnals of Allergy, Asthma & Immunology, 2023
- Tezepelumab: First ApprovalDrugs, 2022
- Health-related quality of life and drug treatment satisfaction were low and correlated negatively with symptoms in patients having severe refractory chronic rhinosinusitis with nasal polypsAllergology International, 2021
- Rhinologic disease and its impact on sleep: a systematic reviewInternational Forum of Allergy & Rhinology, 2020
- Eosinophilic chronic rhinosinusitisAllergology International, 2019
- Expression of IL‐33 and its receptor ST2 in chronic rhinosinusitis with nasal polypsThe Laryngoscope, 2013
- Impact of residual ethmoid cells on postoperative course after endoscopic sinus surgery for chronic rhinosinusitisAuris Nasus Larynx, 2012
- TSLP enhances the function of helper type 2 cellsEuropean Journal of Immunology, 2011
- Oral steroids and doxycycline: Two different approaches to treat nasal polypsJournal of Allergy and Clinical Immunology, 2010